Search results
Arm Holdings target lifted at Bernstein but 'valuation looks very full' By Investing.com
Investing.com· 58 minutes agoBernstein upped the price target on Arm Holdings (NASDAQ:ARM) to $92 from $72 on Thursday, although...
BT shares soar as British broadband provider targets another £3 billion in cost cuts
CNBC· 2 hours agoShares of BT Group surged Thursday after the firm announced a target of a further £3 billion ($3.8...
UNC basketball transfer portal target still focused on 2024 NBA Draft
Tar Heels Wire via Yahoo Sports· 2 hours agoHubert Davis and the UNC basketball program have struck out on a few different targets in the...
PepsiCo target raised at Jefferies as PBNA margins expected to finally inflect By Investing.com
Investing.com· 1 hour agoPepsiCo target raised at Jefferies as PBNA margins expected to finally inflect
NICE recommends targeted radiation therapy for liver tumours
Medical Device Network via Yahoo Finance· 24 minutes agoNew guidance from the National Institute for Health and Care Excellence (NICE) recommends that...
Renalytix AI shares target cut, maintains buy rating By Investing.com
Investing.com· 2 hours agoOn Thursday, BTIG adjusted its outlook on Renalytix AI Plc. (NASDAQ:RNLX), reducing the price target...
Jones Trading cuts TFF Pharmaceuticals shares target on single-product risk By Investing.com
Investing.com· 34 minutes agoOn Thursday, Jones Trading adjusted its outlook on TFF Pharmaceuticals (NASDAQ:TFFP) shares,...
AGF Management Ltd. Buys 148 Shares of Target Co. (NYSE:TGT)
ETF DAILY NEWS· 4 hours agoAGF Management Ltd. lifted its stake in shares of Target Co. (NYSE:TGT – Free Report) by 3.6% in the...
Spire Global shares target cut by Canaccord on solar cycle impact By Investing.com
Investing.com· 3 hours agoOn Thursday, Canaccord Genuity (TSX:CF) adjusted its price target for Spire (NYSE:SR) Global (NYSE:...
Canaccord cuts Aptose Biosciences shares target, expects lead drug approval delay By Investing.com
Investing.com· 3 hours agoOn Thursday, Canaccord Genuity (TSX:CF) adjusted its price target on Aptose Biosciences...